Imugene Limited (ASX:IMU) Announces Positive Phase 1b Trial Results for Azer-cel
Imugene Limited (ASX:IMU) reports 75% response rate in Phase 1b trial of azer-cel for relapsed diffuse large B-cell lymphoma.

Imugene Limited (ASX:IMU) reports 75% response rate in Phase 1b trial of azer-cel for relapsed diffuse large B-cell lymphoma.
Ausgold Limited (ASX:AUC) raises $35 million through share placement to advance the Katanning Gold Project, supported by leading investors.
Orthocell (ASX:OCC) records first US sales revenue from Remplirâ„¢ nerve repair product, marking a significant milestone in US expansion.
Mach7 Technologies (ASX:M7T) updates its FY25 guidance, initiates a share buyback, and announces an investor webinar with the new CEO.
Netwealth Group Limited (ASX:NWL) reports a 40% increase in Funds Under Administration net flows for FY25, highlighting strong financial performance and strategic growth.
Zenith Minerals Limited (ASX:ZNC) completes a A$3.5M Rights Issue to boost gold exploration and resource growth.
Finbar Group Limited (ASX:FRI) acquires Palmyra site for $5.5 million, enhancing its development pipeline and shareholder value.
Mineral Commodities Ltd (ASX:MRC) updates the sale of Skaland Graphite Project, including new payment commitments and a revised closing date.
West African Resources (ASX:WAF) reports Q2 gold production of 45,611 oz and operational progress at Kiaka, achieving first gold pour.
Biome Australia Limited (ASX:BIO) reports a 41% revenue increase in FY25, highlighting strong performance in Q4 and June.